virus covid-19 testing

FDA authorizes company for rapid ‘point-of-care’ test for COVID-19

Reading now: 918
www.clickorlando.com

ORLANDO, Fla. – The Food and Drug Administration approved the first coronavirus test that will be tested entirely at the point of care for a patient, according to a news release.

Cepheid, a molecular diagnostics company, announced Saturday that it has received Emergency Use Authorization from the U.S. Food and Drug Administration for Xpert Xpress SARS-CoV-2.

The rapid molecular diagnostic test is able to detect SARS-CoV-2, the virus causing COVID-19. According to Cepheid, the test is able to deliver results in 45 minutes. “During this time of increased demand for hospital services, Clinicians urgently need an on-demand diagnostic test for real-time management of patients being evaluated for admission to health-care facilities.

Read more on clickorlando.com
The website covid-19.rehab is an aggregator of news from open sources. The source is indicated at the beginning and at the end of the announcement. You can send a complaint on the news if you find it unreliable.

Related News

DMCA